ProfileGDS5822 / ILMN_1244259
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 35% 35% 52% 39% 37% 1% 46% 41% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.935
GSM1276600PDAC Late Ablation Control 218.735
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 120.652
GSM1276603PDAC Late Ablation 218.139
GSM1276604PDAC Late Ablation 318.137
GSM1303940PDAC Late Ablation_anti-CTLA4 13.81
GSM1303941PDAC Late Ablation_anti-CTLA4 222.746
GSM1303942PDAC Late Ablation_anti-CTLA4 319.941